Skip to content

L changes

Pick any two versions below to diff them.

View the full Nov 20, 2026 version
Price
CA$68.99 → CA$71.45(+3.6%)
Next earnings
Nov 19, 2026 → Feb 19, 2027
Next earnings is estimate
No → Yes
About
Loblaw Companies (Loblaw) is the largest food and pharmacy retailer in Canada. It operates supermarkets, hard discount stores and drug stores under banners such as Loblaws, Real Canadian Superstore, No Frills, Maxi, T&T and Shoppers Drug Mart, and it sells its own brands President's Choice and no name. Its PC Optimum loyalty program had more than 18 million active members in 2025. At removed: June 20, added: October 10, 2026, Loblaw had removed: 2,523 added: 2,540 stores and removed: 73.8 added: 74.2 million square feet of retail space, and in Q2 2026 it opened its first T&T store in California. Loblaw also has businesses in supply chain services, retail media and data, and Lifemark health clinics. On July 1, 2026, it sold President's Choice Bank to EQB Inc. and now owns about 19.9% of EQB. In 2025, a year with one extra week, revenue was C$63,903 million. George Weston Limited owns about 52.6% of the common shares. The shares trade on the Toronto Stock Exchange. The head office is in Brampton, Ontario. Per Bank is President and Chief Executive Officer.
Thesis
Loblaw trades above its intrinsic value because investors pay for its steady earnings growth, its strong position in Canadian food and pharmacy retail and its large share buybacks. Adjusted added: diluted EPS from continuing operations rose removed: 8.8% added: 11.4% in the first removed: half added: 40 weeks of 2026, and Loblaw bought back removed: 19.0 added: 27.3 million shares for removed: C$1,200 added: C$1,724 million in that time. At its Investor Day on September 9, 2026, Loblaw set a long-term target of adjusted EPS growth of about 8% to 10% a year. For the shares to earn this price, three things must be true. Discount banners and Shoppers Drug Mart must keep growing their sales, although Food Retail same-store sales grew only removed: 1.6% added: 0.6% in removed: Q2 2026. added: Q3 2026 and store traffic fell. Retail earnings must grow faster than sales, as the 2026 outlook says. The new growth businesses and the share of EQB income must add to earnings, so that their contribution doubles by 2031. The removed: Q3 2026 removed: report on November 19, 2026 is added: results and the added: 2027 outlook, expected in February 2027, are the next test. Slower food sales, more price competition or new rules on grocery prices can make the premium hard to keep.
Risks
Food retail in Canada is very competitive. Other grocers, discount stores and online sellers compete on price, and more sales in discount stores can lower margins. added: In Q3 2026, Food Retail traffic fell on a same-store basis. Changes to laws and rules, for example on prices, supplier terms or competition, can limit margins. Drug Retail depends on prescription drug prices that governments set. A reduction of generic drug prices or of professional allowances can lower earnings. Loblaw now owns about 19.9% of EQB. Its share of EQB income depends on the results of a bank, which can change with credit losses and interest rates. added: In Q3 2026, the first credit loss provisions of EQB on the PC Financial loans gave Loblaw a loss of C$26 million from this investment. George Weston Limited owns about 52.6% of the shares and controls Loblaw. Its interests can differ from those of other shareholders.
Balance sheet
Cash: CA$1.0B Debt: removed: CA$5.9B added: CA$6.1B Net debt: removed: CA$4.9B added: CA$5.1B Undrawn credit line: removed: CA$1.5B, added: CA$1.4B, to March 2030 Ratings: S&P BBB+ (stable outlook) Loblaw funds itself with cash flow, debentures and leases. At removed: June 20, added: October 10, 2026, cash and cash equivalents were removed: C$998 million added: C$1,049 million, and added: Loblaw had no short-term removed: investments C$14 million. added: investments. Long-term debt was removed: C$5,912 million, mainly added: C$6,103 million: debentures of removed: C$5,202 added: C$5,201 million, added: independent funding trusts of C$767 million and removed: none added: C$150 million drawn on the committed credit facility. None of it was due within one year. Lease liabilities were removed: C$10,666 added: C$10,821 million. Total debt excluding leases, with certain other liabilities, was removed: C$6,242 added: C$6,431 million. Debt to rolling year adjusted EBITDA, as Loblaw measures it, was 2.3 times. The committed credit facility of C$1.5 removed: billion, which added: billion ends on March 27, 2030, added: and C$1,350 million of it was undrawn. S&P rates the issuer BBB+ with a stable outlook. added: The investment in EQB and other equity-accounted investments was C$1,262 million. In the first removed: half added: 40 weeks of 2026, added: free cash flow from continuing operations was C$1,612 million, and Loblaw bought back removed: 19.0 added: 27.3 million shares for removed: C$1,200 million, and 1,157,499,810 added: C$1,724 million. 1,150,054,561 shares were outstanding at removed: June 20, added: October 10, 2026. removed: The added: On November 18, 2026, the sale of removed: President's Choice Bank on July 1, 2026 added: QHR Technologies gave removed: C$235 added: about C$236 million in removed: cash and 7.2 million EQB shares. added: cash. The quarterly dividend is C$0.155183 per removed: share. added: share, and the next one is payable on December 30, 2026. As of removed: Jun 20, added: Oct 10, 2026.
Checkpoints
Jul 30, 2026: Q2 2026 results and the 2026 outlook. Passed. Watch: Adjusted EPS growth of 8% or more and a kept outlook pass; a lower outlook fails. Outcome: Adjusted EPS rose 11.9% to C$0.66, and Loblaw kept its 2026 outlook. Nov 19, 2026: Q3 2026 results, the first quarter without President's Choice Bank. removed: Pending. added: Passed. Watch: Adjusted EPS growth from continuing operations of 8% or more and positive Food Retail same-store sales pass; lower adjusted EPS fails. added: Outcome: Adjusted diluted EPS from continuing operations rose 15.6% to C$0.74, and Food Retail same-store sales grew 0.6%. Feb added: 19, 2027 (estimate): 2026 results and the 2027 outlook. Pending. Watch: 2026 adjusted EPS growth in the high single digits and a 2027 outlook in line with the 8% to 10% framework pass; a lower outlook fails.
Recent events
added: Nov 19, 2026: Loblaw reported Q3 2026 results, the first quarter without President's Choice Bank. Retail sales rose 3.6% to C$19,857 million, with Food Retail same-store sales growth of 0.6% and Drug Retail same-store sales growth of 4.8%. Adjusted diluted EPS from continuing operations rose 15.6% to C$0.74, and total adjusted diluted EPS rose 8.8%. Net earnings included a gain of C$401 million on the sale of PC Financial. Loblaw bought back 8.3 million shares for C$524 million in the quarter and kept its 2026 outlook of adjusted EPS growth in the high single digits. Nov 18, 2026: Loblaw sold its interest in QHR Technologies, a maker of medical record software, to LGI Healthcare Solutions for about C$236 million in cash. Loblaw will record the gain in Q4 2026. Sep added: 30, 2026: The Competition Bureau started an investigation of minimum advertised pricing policies of large consumer goods suppliers. Loblaw said that it supports this investigation and the Bureau's review of competition across the food supply chain. Sep 9, 2026: At its Investor Day, Loblaw set a long-term financial framework that targets adjusted EPS growth of about 8% to 10% a year. It expects supply chain services, retail media and data, Lifemark, the T&T expansion in the United States and the EQB income to give about 10% of operating income in 2026, and their contribution to double by 2031. Jul 30, 2026: Loblaw reported Q2 2026 results. Retail sales rose 4.1% to C$15,046 million, with Food Retail same-store sales growth of 1.6% and Drug Retail same-store sales growth of 4.6%. Adjusted EPS rose 11.9% to C$0.66. Loblaw bought back 8.8 million shares for C$552 million in the quarter and kept its 2026 outlook of adjusted EPS growth in the high single digits. Jul 1, 2026: Loblaw completed the sale of President's Choice Bank and related businesses to EQB Inc. for C$1,234 million, which included 7.2 million EQB shares worth C$963 million and C$235 million in cash. Loblaw now owns about 19.9% of EQB and expects a gain of about C$375 million before tax in Q3 2026. May 6, 2026: Loblaw reported Q1 2026 results. Net earnings available to common shareholders rose 18.1% to C$594 million, or C$0.50 per share, and adjusted EPS rose 10.6% to C$0.52. It opened 5 hard discount stores and 8 drug stores.